Subscribe
shutterstock_1843221310_maxshot_pl
MAXSHOT.PL / Shutterstock.com
3 May 2022Alex Baldwin

Swiss scientist convicted for GSK trade secrets theft

A scientist working in Switzerland has been convicted of conspiring with his sister and others to steal trade secrets from GlaxoSmithKline (GSK) for the benefit of their respective biopharmaceutical ventures.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
UK pharma firm ‘stole’ psilocybin secrets from professor
9 August 2022   Mental health specialists in dispute over psilocybin | Terran Biosciences accuses Compass Pathways of ‘milking’ professor before ‘secretly’ filing a patent for the medicine.
Big Pharma
GSK presses court to deny Teva’s ‘skinny label’ petition
25 August 2022   Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.
Big Pharma
Cigna pursues trade secrets in ‘non-competes’ dispute
31 January 2023   Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
UK pharma firm ‘stole’ psilocybin secrets from professor
9 August 2022   Mental health specialists in dispute over psilocybin | Terran Biosciences accuses Compass Pathways of ‘milking’ professor before ‘secretly’ filing a patent for the medicine.
Big Pharma
GSK presses court to deny Teva’s ‘skinny label’ petition
25 August 2022   Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.
Big Pharma
Cigna pursues trade secrets in ‘non-competes’ dispute
31 January 2023   Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.

More on this story

Americas
UK pharma firm ‘stole’ psilocybin secrets from professor
9 August 2022   Mental health specialists in dispute over psilocybin | Terran Biosciences accuses Compass Pathways of ‘milking’ professor before ‘secretly’ filing a patent for the medicine.
Big Pharma
GSK presses court to deny Teva’s ‘skinny label’ petition
25 August 2022   Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.
Big Pharma
Cigna pursues trade secrets in ‘non-competes’ dispute
31 January 2023   Move comes as Federal Trade Commission proposes controversial ban on non-compete clauses | Former executive requested list of “top clients” on day of resignation.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York